Physician profile
Jordan Klebanoff
NPI 1437578655
$186,831.19
in general payments reported to CMS, 2019-2025
17 companies · $88K in 2025
The $88K reported for 2025 was more than what 99% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2021: $241 · 2022: $2,487 · 2023: $57K · 2024: $39K · 2025: $88K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $128K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $25K · Travel and Lodging: $21K · Food and Beverage: $6,137 · Consulting Fee: $4,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $128,200.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24,500.00 |
| Travel and Lodging | $20,952.96 |
| Food and Beverage | $6,137.07 |
| Consulting Fee | $4,080.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $179,659.34 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Pfizer INC. | $4,971.82 | 2023-2024 | |
| Abbvie INC. | $595.75 | 2019-2023 | |
| Myovant Sciences INC. | $386.52 | 2021-2022 | |
| Hologic Sales and Service, LLC | $317.01 | 2019-2024 | Acessa Provu System |
| Sumitomo Pharma America, INC. | $207.07 | 2023-2025 | Myfembree |
| Coopersurgical, INC. | $161.18 | 2023-2024 | Advincula Delineator Uterine Manipulator, Paragard T 380a |
| Medtronic, INC. | $141.43 | 2023-2024 | Ligasure, Truclear |
| Aspira Women'S Health INC | $123.58 | 2023-2025 | Ova1 |
| Bayer Healthcare Pharmaceuticals INC. | $91.20 | 2022-2023 | |
| Virtus Pharmaceuticals LLC | $46.91 | 2021-2022 | |
| Minerva Surgical, INC | $35.49 | 2023-2024 | |
| Mylan Pharmaceuticals INC. | $21.64 | 2022 | |
| Mayne Pharma Commercial LLC | $21.15 | 2025 | |
| Olympus America INC. | $19.72 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $17.89 | 2022 | |
| Conmed Corporation | $13.49 | 2024 | Airseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Klebanoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.